Ironwood to Acquire Rare Disease Specialist VectivBio for US$1 B
By Lucy Haggerty
Pharma Deals Review: Vol 2023 Issue 5 (Table of Contents)
Published: 26 May-2023
DOI: 10.3833/pdr.v2023.i5.2787 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand its rare gastrointestinal pipeline, Ironwood Pharmaceuticals has agreed to acquire VectivBio for an aggregate consideration of approximately US$1 B...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS